This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Jacob, M Articles by Mannherz, H G Search for Related Content PubMed PubMed Citation Articles by Jacob, M Articles by Mannherz, H G Social Bookmarking                   What's this?

Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice

M Napirei

A Ricken

Abteilung für Anatomie und Embryologie, Ruhr-Universität Bochum, Bochum, Germany

C Dixkens

Abteilung für Medizinische Genetik, Universität Ulm-Klinikum, Ulm, Germany

H G Mannherz

Abteilung für Anatomie und Embryologie, Universitätsstrasse 150, D-44780 Bochum, Germany; hans.g.mannherz{at}ruhr-uni-bochum.de

Deoxyribonuclease 1 (Dnase1)-de"cient mice develop symptoms of Systemic lupus erythematosus (SLE). Here we analysed the renal histopathology of these animals in comparison to F1 hybrids of New Zealand black and white mice (NZB/W F1), an established model of SLE. Animals were divided into three groups according to the presence of anti-nuclear antibodies (ANA) and renal lesions. Groups 1a–1c were healthy, whereas group 2 and 3 were classified as lupus-prone and affected. Subendothelial and/or mesangial immune complex deposits, mesangial and endocapillary proliferation,haematoxylin bodies and platelet aggregation were detected in both mouse strains but were more severe in the NZB/W F1 mice. The lupus nephritis was classi"ed as a proliferating (WHO type III or IV), which appeared to be preceded by a mesangial form (WHO type II). Subclassification of the ANA revealed a high prevalence of anti-nucleosome antibodies in Dnase1-deficient mice, whereas NZB/W F1 mice developed autoantibodies against a broad range of chromatin constituents. Mapping of the murine Dnase1 gene locus to chromosome 16A1-3 did not coincide with one of the reported susceptibility loci in the NZB/W F1 model, although a reduced Dnase1 serum and urine activity has been described previously in these mice.

Key Words: ANA • Dnase1 • NZB/W F1 mice • SLE

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?